Cytocom

Fort Collins, United States

Cytocom is a biopharmaceutical company focused on analogs that treat multiple diseases.

$75.0M raised

Jul 2021

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Cytocom raised?

Cytocom has raised $75.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in July 2021.

Who are Cytocom's investors?

Cytocom's investors include Avenue Capital Group, Adit Ventures, The Global Emerging Markets Group.

Where is Cytocom headquartered?

Cytocom is headquartered in Fort Collins, United States.

What does Cytocom do?

Cytocom is a biopharmaceutical company focused on analogs that treat multiple diseases.

What stage is Cytocom at?

Cytocom is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 29, 2021.

MLA

"Cytocom — Funding & Investors." VCBacked, July 29, 2021, https://www.vcbacked.co/company/cytocom. Accessed July 2, 2026.

APA

VCBacked. (2021). Cytocom — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/cytocom

Wikipedia (cite web)

{{cite web |title=Cytocom — Funding & Investors |url=https://www.vcbacked.co/company/cytocom |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 29, 2021.